What is Adnexal tumors?

These are diverse tumor masses, normally benign, that appear in the areas surrounding the uterine organs and tissues, such as:

Ovaries.
Fallopian tube.
Connective tissue material around these organs.

Although they can appear at any age, adnexal tumors arise with some frequency in women of reproductive age, and may be:

Neoplastic.
Congenital.
Physiological.
Hemorrhagic.
Inflammatory.
Obstructive.

Its therapeutic management should be based on the nature of the tumor, its location, size, and the available treatment options, which do not always indicate surgery as the first option.

The most important thing in adnexal tumors is to verify that they are not cancerous since ovarian cancer has a high mortality rate.

Signs and symptoms Adnexal tumors

Generally, adnexal tumors do not have symptoms, but when they do, the following may occur:

Inflammation.
Pelvic discomfort.
Low back pain.
Frequent urination.
Intestinal alterations.

Diagnosis and treatment Adnexal tumors

As they do not usually cause symptoms, adnexal tumors are usually diagnosed accidentally during routine gynecological examinations. However, if you have symptoms, the doctor will analyze them along with your medical history, and subsequently perform a physical examination and a thorough pelvic examination.

They will also perform a series of tests to rule out other conditions, confirm the diagnosis, and verify they are benign, such as:

Blood test.
Ultrasound.
Computed tomography.
Tissue biopsy.

The treatment to follow will depend on the type of tumor, its size, and its location, but generally includes:

Observation.
Symptoms control (if any).
Surgery.

Comprehensive women’s health is our priority at the Women’s Center, so we offer services focused on women in all their chronological stages with the highest standards of care to improve their quality of life, through a wide range of prevention, diagnosis, timely treatment, and follow-up services.

Related centers and departments

Women’s Center
Radiology and Molecular Imaging
Clinical Laboratory

Fuentes:

elsevier.es
cun.es
topdoctors.es
wnyurology.com
mayoclinic.org
medlineplus.gov
msdmanuals.com
medigraphic.com
Ramírez-López P, Pérez-López JC, Mandujano-Álvarez GJ, et al. Quiste gigante de Naboth como diagnóstico diferencial de los tumores anexiales. Case report. Ginecol Obstet Mex. 2020;88(02):118-122.
Florat GD, Marrero CY, Rodríguez VKM. Siringomas vulvares. Presentación de un caso. Dermatología Cosmética, Médica y Quirúrgica. 2019;17(4):275-278.
González-Burgos OM, Álvarez-Licona NE, Lever-Rosas CD. Comparación de tres índices ecográficos para evaluación del riesgo de malignidad de los tumores anexiales. Ginecol Obstet Mex. 2018;86(08):519-529.
Rodríguez SS, Ciancio RM, Cabo H. Estudio dermatoscópico de los siringomas periorbitarios. Med Cutan Iber Lat Am. 2015;43(2):132-135.

How can we help you?

The dissemination of the content of this material is for informational purposes only and does not replace, under any circumstance or condition, a consultation with a specialist doctor, for which the ABC Medical Center is not responsible for the different use that may be given to it. If you require more information related to the subject, we suggest you contact the specialist doctor you trust directly.

Index

Content

Get from 3 to 9 interest-free installments* with American Express or 6 installments* when paying with Citibanamex, BBVA, HSBC, Santander or 12 installments*
when paying with Citibanamex.

Comparison of COVID-19 vaccines

Pfizer-
BioNTech

Pfizer-BioNTech

What is its effectiveness and what does it refer to?

Vaccine type: mRNA
Effectiveness: 95% after the second dose in the prevention of symptomatic COVID-19.

No Does not contain egg, latex, or preservatives.

How many doses are needed?
Two doses are needed, at least 21 days apart (or up to six weeks apart, if necessary).

Who should or shouldn’t get the vaccine?
People who should receive the vaccine are those over 16 years old.
People who should not receive the vaccine are those who have a history of anaphylactic shock (severe allergy) or who are allergic to any component of this vaccine such as polyethylene glycol (PEG) or polysorbate.

What are the possible side effects of the vaccine?
Pain where the injection was given, fatigue, headache, muscle pain, chills, joint pain, fever, nausea, malaise, and swollen lymph nodes.

How long will it take for me to be protected and what does it protect me from?
After 14 days of having the complete scheme (after the administration of the 2nd dose), the protection period is still under study. It protects us from serious COVID-19 or requiring hospitalization.

Moderna

What is its effectiveness and what does it refer to?

Vaccine type: mRNA
Effectiveness: 94.5% after the second dose in the prevention of symptomatic COVID-19.

Does not contain egg, latex, or preservatives.

How many doses are needed?
Two doses are needed, at least 28 days apart (or up to six weeks apart, if necessary).

Who should or shouldn’t get the vaccine?
People who should receive the vaccine are those over 18 years old.
People who should not receive the vaccine are those who have a history of anaphylactic shock (severe allergy) or who are allergic to any component of this vaccine.

What are the possible side effects of the vaccine?
Pain where the injection was given, fatigue, headache, muscle pain, chills, joint pain, fever, nausea, and swollen lymph nodes in the arm in which you received the injection.

Janssen/
Johnson
& Johnson

Janssen/ Johnson & Johnson

What is its effectiveness and what does it refer to?

Vector-based vaccine.
Effectiveness: 72.0% in the prevention of symptomatic COVID-19.
85% in the prevention of severe COVID-19.

Does not contain egg, latex, or preservatives./strong>

How many doses are needed?
Only one dose in needed.

What are the possible side effects of the vaccine?
Pain where the injection was given, headache, fatigue, muscle pain, chills, fever, and nausea.

How long will it take for me to be protected and what does it protect me from?
After 28 days of having the complete scheme (the last dose applied), the protection period is still under study. It protects us from 85% serious COVID-19 or requiring hospitalization.

AstraZeneca
and
Oxford
University

AstraZeneca and Oxford University

What is its effectiveness and what does it refer to?

Adenovirus vector-based vaccine.
Effectiveness: 82% after the second dose in the prevention of symptomatic COVID-19.

How many doses are needed?
Two doses are needed, at least 56 days apart (or up to 84 days apart, if necessary).

What are the possible side effects of the vaccine?
Pain where the injection was given, fatigue, headache, myalgia, arthralgia, and fever, which were mild to moderate in intensity and disappeared within 48 hours of vaccination.

Sputnik V

What is its effectiveness and what does it refer to?

Adenovirus vector-based vaccine.
Effectiveness: 92% after the second dose in the prevention of symptomatic COVID-19.

How many doses are needed?
Two doses are needed, at least 21 days apart (or up to six weeks apart, if necessary).

What is Adnexal tumors?

Signs and symptoms Adnexal tumors

Diagnosis and treatment Adnexal tumors

Related centers and departments

Fuentes:

Index

Specialist in Adnexal tumors